We shifted CADTH’s annual, in-person, signature event — the 2020 CADTH Symposium — into a successful and engaging virtual one.

We developed new communications tools, including a COVID-specific microsite, a weekly CADTH COVID-19 Update newsletter, and a well-attended lecture series that shared the latest COVID-19 information and best practices.

We expanded the scope of our business beyond assessing drugs and medical devices to responding to a range of COVID-19–related questions.

We assessed and reported on emerging COVID-19 evidence as soon as it was available, which included conducting our first Ultra-Rapid Review and our first Living Rapid Review.